Nasdaq News

Image source: The Motley Fool.

Image source: The Motley Fool.

There are a number of societal shifts happening in the midst of the COVID-19 pandemic that will outlast the outbreak itself.

Aurora Cannabis (NYSE: ACB) needs to improve its performance this year. There's just no way around that. The stock is down more than 65% in the first four months of 2020; it's performing much worse than the Horizons Marijuana Life Sciences ETF (OTC: HMLSF), which has declined by

The tech sector hosts plenty of growth stocks, but it can be tough to identify the highest growth companies as the economic fallout from the COVID-19 pandemic ravages markets worldwide. To narrow down the list, I recently pulled together an analysis that focused on stocks with r

Millions of Americans, many of whom have never filed for unemployment before, are now relying on it as their primary source of income until the COVID-19 pandemic subsides. Thanks to the CARES Act, they can now look forward to an extra $600 per week, and they can claim benefits f

Image source: The Motley Fool.

I'm a big fan of solar, and in particular, solar-panel manufacturing giant First Solar (NASDAQ: FSLR). A leader in building solar panels for the utility-scale segment, First Solar also has by far the strongest balance sheet of any solar company, giving it a massive leg up in wha

The stock market has bounced 35% higher from the bottom of the first wave of the coronavirus pandemic. This sharp recovery still left a lot of great stocks trading at invitingly low share prices. As master investor Ben Graham wrote in his classic tome, The Intelligent Investor,

Vertex Pharmaceuticals (NASDAQ: VRTX) and Alexion Pharmaceuticals (NASDAQ: ALXN) have each figured out the same winning strategy. Focus on a rare genetic disease. Develop an effective drug for it. Achieve commercial success. Then repeat the process.

Many dividend stocks have either cut or stopped their payouts entirely as a result of the coronavirus pandemic. Hardly any businesses are actually increasing them -- after all, raising dividend payments is a big move to make at a time when no one really knows what's in store for

AbbVie's (NYSE: ABBV) share price has been hit pretty hard this year by the COVID-19 pandemic. But its underlying business hasn't.

The CARES Act provided funding for most Americans to receive stimulus payments (formally known as Economic Impact Payments) of as much as $1,200 per adult and $500 for every qualifying child. And in mid-April, the IRS launched an online portal, known as Get My Payment, that allo

Identifying tomorrow's stock market winners requires unwavering curiosity. Separating genius ideas from the crazy, filtering the doable from the impossible, and then evaluating financial feasibility is a lot of work. It's also a lot of fun and a bit of a numbers game.

We're told we're supposed to save for emergencies, and the COVID-19 crisis most definitely qualifies as one. But what if you never managed to put together an emergency fund, and now your bank account is virtually empty? That's bad news if you've lost your job, or if your income

Starbucks (NASDAQ: SBUX) says it's on the road to recovery in China after the coronavirus outbreak led to a 50% drop in same-store sales in the second quarter of fiscal 2020. Revenue also fell by $325 million there amid the temporary halt to business.

Cannabis consumers, like all consumers, are missing out on the in-store shopping experience during the coronavirus pandemic. Many marijuana customers enjoy the benefit of asking the staff at a pot shop for suggestions on what to buy, but that's currently not possible; consumers

Global pharmaceutical giant AstraZeneca (NYSE: AZN) heralded new overall survival data this week from a pivotal phase 3 clinical trial for patients with certain types of advanced-stage prostate cancer. Patients treated with the company's blockbuster drug Lynparza lived longer th

With investors fleeing risk as the pandemic spreads and interest rates plummet, you'd think that investors in stocks that pay a dependable stream of dividends would be relatively happy right now. Or at least, maybe they'd be less sad than growth investors at the moment.

(RTTNews) - Microsoft (MSFT) is in talks to buy Softomotive Ltd., a UK-based provider of robotic process automation solutions, Bloomberg reported citing people familiar with the matter.